Implantable Cardioverter Defibrillator Market Is Growing With A Healthy CAGR Rate (2.7%)
Emergen Research Logo
Implantable cardioverter defibrillator market revenue growth is driven by rising focus on public-access defibrillators and training and awareness programs
VANCOUVER, BC, CANADA, August 30, 2022 /EINPresswire.com/ -- The global Implantable Cardioverter Defibrillator (ICD) market size is expected to reach USD 8.81 Billion at a steady CAGR of 2.7% in 2028, according to latest analysis by Emergen Research. The market for implantable cardioverter defibrillators is growing due to an increase in prevalence of cardiac diseases. Surge in risk factors such as obesity and rise in sedentary lifestyle are other key factors driving the growth of ICD market. Implantable cardioverter defibrillator is a small battery powered device placed on an individual’s chest to monitor heart rhythm and detect abnormal heartbeats. The device can deliver electric shocks via wires to fix heart arrhythmias.
The Implantable Cardioverter Defibrillator Market Report contains current and future technical and financial industry data. The report provides a detailed analysis of market characteristics, size and growth, segmentation, breakdowns by region and country, and the competitive landscape. In addition, this report examines all the key factors influencing the growth of the global market, including the supply and demand scenario, pricing structure, profit margins, production and value chain analysis. Research indicates the widespread use of both primary and secondary data sources.
Get Free Sample Report + All Related Graphs & Charts@ https://www.emergenresearch.com/request-sample/732
Key Highlights of Report
In February 2020, Abbott announced that it has received CE Mark for its Gallant implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator devices, bringing advanced heart rhythm management capabilities to the market in Europe. The new device opens up potential for remote monitoring and patient engagement through connected applications. Other benefits of the product includes improved battery life, patient preferred design, and MRI compatibility.
Subcutaneous ICD (S-ICD) segment accounted for a significantly large revenue share in 2020. S-ICD has advantages over traditional systems, especially for young patients in whom the risk of device-related complications is extremely high. Moreover, S-ICD poses no risk of pneumothorax or vascular injury. S-ICD has cosmetic advantages due to its anatomic location despite its larger size.
Hospitals & clinics segment accounted for largest revenue share in 2020 as these settings are the major point of care for treatment of heart diseases, including cardiac arrest. Rising incidence of deaths due to cardiovascular diseases is driving revenue growth of this segment as hospitals have advanced medical infrastructure and treatment facilities.
In the next section of the Implantable Cardioverter Defibrillator market report, readers present thoughts that stimulate insight into a variety of key aspects, including product portfolios, payment structures, trading interfaces, as well as technical sophistication that decisively enlightens the growth prognosis of the target market. A thorough analysis of the dissolution of local stars is also included in the trailing section of the report before conducting a competitive environment overview.
Prominent Players Analyzed in the Report:
Boston Scientific Corporation, Abbott Laboratories, Biotronik, Medtronic PLC, LivaNova PLC, MicroPort, Sorin Group, Koninklijke Philips N.V., Fukuda Denshi Co. Ltd., and Physio-Control, Inc.
To obtain all-inclusive information, visit @ https://www.emergenresearch.com/industry-report/implantable-cardioverter-defibrillator-market
Furthermore, the report divides the Implantable Cardioverter Defibrillator market into key segments and sub-segments to offer an analysis of the product type and application spectrum of the industry. It also offers predictions about the segments expected to show significant growth during the projected timeline.
Emergen Research has segmented the global implantable cardioverter defibrillator market on the basis of product type, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
Transvenous ICD
Single Chamber ICD
Dual Chamber ICD
CRT-D (cardiac resynchronization therapy-defibrillator)
Subcutaneous ICD
End-use Channel Outlook (Revenue, USD Billion; 2018–2028)
Hospitals & Clinics
Ambulatory Surgery Centers
Others
Make an enquiry of this report @ https://www.emergenresearch.com/purchase-enquiry/732
The report covers key points of the market, including the standards, regulations, and policy changes applied by the government on the industry for the coming years. The report encompasses thorough research carried out by the application of advanced analytical tools such as SWOT analysis and Porter’s Five Forces analysis to pinpoint the growth trends and patterns. Factors likely to influence the growth of the market, current trends, opportunities,
In conclusion, the report is designed to provide an in-depth analysis of all the key change calculation factors that replicate the decisions that trigger the change, which pushes the player’s winning position profitable on the growth curve despite massive competition in the target Implantable Cardioverter Defibrillator market.
Overview of the Implantable Cardioverter Defibrillator Market Report:
Introduction, Product Scope, Market Overview, and Opportunities
Analysis of the Manufacturers with sales, revenue, and price analysis
Comprehensive analysis of the competitive landscape
Extensive profiling of the key competitors along with their business strategies and market size
Regional analysis of the market along with sales, revenue, market share, and global position
Country-wise analysis of the market along with types, applications, and manufacturing
Strategic recommendations to established players as well as new entrants
In-depth analysis of the risks, restraints, and limitations in the Implantable Cardioverter Defibrillator industry
Enquire for customization in Report @: https://www.emergenresearch.com/request-for-customization/732
Thank you for reading our report. Please connect with us to know more about the report or the customization of the report. Our team will ensure the report is best suited to meet your requirements.
Look Over transcripts provided by Emergen Research
DNA Methylation Market
Agricultural Robots Market
Semiconductor Laser Market
Automotive Camera Market
Metal Foam Market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
The global Implantable Cardioverter Defibrillator (ICD) market size is expected to reach USD 8.81 Billion at a steady CAGR of 2.7% in 2028
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
